cannabidiol (CBD)

With the emergence of CBD-based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers through the bioavailability challenges facing this sector of the industry. Read more


A recent report has revealed a worrying variation in the quality of cannabidiol (CBD) products currently available. Read more


Medical cannabis will be produced and distributed across Europe following a new partnership between cannabidiol (CBD) group Dragonfly Biosciences and a leading cGMP pharmaceutical company in Malta. Read more


As a part of its ongoing efforts to protect consumers, the US FDA has issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat or cure cancer without support evidence. Read more